Consolidated Portfolio Review Corp recently decreased its stake in Oracle Co. by 62.8% during the first quarter, selling 2,895 shares and leaving them with 1,717 shares worth $216,000. Other institutional investors have also adjusted their holdings in Oracle. Insiders such as Director George H. Conrad and Edward Screven have sold shares in recent transactions. In the last ninety days, insiders have sold 385,639 shares of the company’s stock, valuing $53,002,729. The company’s stock has received various analyst ratings, with a current consensus rating of “moderate buy” and a price target of $145.83. Oracle’s stock on the NYSE rose to $144.83 on Friday, with a market capitalization of $399.13 billion. The company recently reported quarterly results, missing analyst estimates by $0.02 with earnings per share of $1.63. Oracle also announced a quarterly dividend of $0.40 per share to be paid on July 25th.
Article Source
https://www.defenseworld.net/2024/07/06/consolidated-portfolio-review-corp-has-216000-holdings-in-oracle-co-nyseorcl.html
